Matches in SemOpenAlex for { <https://semopenalex.org/work/W2263017585> ?p ?o ?g. }
Showing items 1 to 89 of
89
with 100 items per page.
- W2263017585 endingPage "64" @default.
- W2263017585 startingPage "56" @default.
- W2263017585 abstract "The Korean Society of Nephrology reports the Multicenter Study on CAPD in diabetics with ESRD. This report based on the analysis of the questionairs distributed to fourteen centers throughout the nation. The results were as follows; 1) As of September, 1987, 626 patients are on CAPD in Korea. Of these, 14.1 per cent of the patients are com- prised of diabetics. 2) Diabetics with ESRD were older than non diabetic patients with ESRD, and it was most prevalent in the fifties. 3) Most of the centers considered CAPD as the treat- ment of choice for the diabetics with ESRD. 4) It takes 14.6 years on average for diabetics to get in end stage renal failure. 5) Most centers tend to start diabetics on dialysis earlier than in nondiabetics, that is, when their serum creatinine reach 9.83 mg/dl on average. 6) Blood sugar levels were reduced after 24 months of CAPD compared to pre CAPD level, but it was not statistically significant. 7) Various hematologic and biochemical indexes such as hemoglobin level, serum albumin level, Ca and phos- phorus levels were improved after starting CAPD. 8) Peritonitis is still a major complication. Each patient experiences 1.9 episodes of peritonitis on aver- age per year. 9) Sizable number of the patients suffered from gas- trointestinal complications, particularly nausea and vomiting and cardiovascular complications. 10) 43 patients succumbed to death while on CAPD. Main cause of death were peritonitis and cardiovascular complications. 11) 26 patients stopped peritoneal dialsysis for var- ious reasons other than death or lost to follow-up, and the major reason was peritonitis comprising of 15 patients. 12) Diabetics with ESRD are not doing well in terms of the rehabilitation. This is partly attributable to old age and to cardiovascular complications. 13) The actuarial survival rate were 95.4%, 90.2%, 79. 2% and 61.0% at 3 months, 6 months, 12 months and 24 months respectively. This is lower than that in non diabetics with ESRD. We conclude that continuous ambulatory peritoneal dialysis is a good alternative treatment for diabetics with end-stage renal disease." @default.
- W2263017585 created "2016-06-24" @default.
- W2263017585 creator A5001089081 @default.
- W2263017585 creator A5012757545 @default.
- W2263017585 creator A5020645012 @default.
- W2263017585 creator A5032339520 @default.
- W2263017585 creator A5035736915 @default.
- W2263017585 creator A5040979727 @default.
- W2263017585 creator A5043584959 @default.
- W2263017585 creator A5043732662 @default.
- W2263017585 creator A5044381871 @default.
- W2263017585 creator A5047048729 @default.
- W2263017585 creator A5048050332 @default.
- W2263017585 creator A5048387207 @default.
- W2263017585 creator A5051862827 @default.
- W2263017585 creator A5053636542 @default.
- W2263017585 creator A5058621331 @default.
- W2263017585 creator A5071453789 @default.
- W2263017585 creator A5073079332 @default.
- W2263017585 creator A5073145802 @default.
- W2263017585 creator A5074581696 @default.
- W2263017585 creator A5077388520 @default.
- W2263017585 creator A5079673477 @default.
- W2263017585 creator A5084653917 @default.
- W2263017585 creator A5086376298 @default.
- W2263017585 date "1987-01-01" @default.
- W2263017585 modified "2023-09-26" @default.
- W2263017585 title "당뇨병환자의 CAPD현황과 환자 및 기술생존율" @default.
- W2263017585 hasPublicationYear "1987" @default.
- W2263017585 type Work @default.
- W2263017585 sameAs 2263017585 @default.
- W2263017585 citedByCount "0" @default.
- W2263017585 crossrefType "journal-article" @default.
- W2263017585 hasAuthorship W2263017585A5001089081 @default.
- W2263017585 hasAuthorship W2263017585A5012757545 @default.
- W2263017585 hasAuthorship W2263017585A5020645012 @default.
- W2263017585 hasAuthorship W2263017585A5032339520 @default.
- W2263017585 hasAuthorship W2263017585A5035736915 @default.
- W2263017585 hasAuthorship W2263017585A5040979727 @default.
- W2263017585 hasAuthorship W2263017585A5043584959 @default.
- W2263017585 hasAuthorship W2263017585A5043732662 @default.
- W2263017585 hasAuthorship W2263017585A5044381871 @default.
- W2263017585 hasAuthorship W2263017585A5047048729 @default.
- W2263017585 hasAuthorship W2263017585A5048050332 @default.
- W2263017585 hasAuthorship W2263017585A5048387207 @default.
- W2263017585 hasAuthorship W2263017585A5051862827 @default.
- W2263017585 hasAuthorship W2263017585A5053636542 @default.
- W2263017585 hasAuthorship W2263017585A5058621331 @default.
- W2263017585 hasAuthorship W2263017585A5071453789 @default.
- W2263017585 hasAuthorship W2263017585A5073079332 @default.
- W2263017585 hasAuthorship W2263017585A5073145802 @default.
- W2263017585 hasAuthorship W2263017585A5074581696 @default.
- W2263017585 hasAuthorship W2263017585A5077388520 @default.
- W2263017585 hasAuthorship W2263017585A5079673477 @default.
- W2263017585 hasAuthorship W2263017585A5084653917 @default.
- W2263017585 hasAuthorship W2263017585A5086376298 @default.
- W2263017585 hasConcept C126322002 @default.
- W2263017585 hasConcept C141071460 @default.
- W2263017585 hasConcept C187212893 @default.
- W2263017585 hasConcept C2779056158 @default.
- W2263017585 hasConcept C2779978075 @default.
- W2263017585 hasConcept C2780199535 @default.
- W2263017585 hasConcept C2780306776 @default.
- W2263017585 hasConcept C2780580376 @default.
- W2263017585 hasConcept C2780852908 @default.
- W2263017585 hasConcept C2909406889 @default.
- W2263017585 hasConcept C71924100 @default.
- W2263017585 hasConceptScore W2263017585C126322002 @default.
- W2263017585 hasConceptScore W2263017585C141071460 @default.
- W2263017585 hasConceptScore W2263017585C187212893 @default.
- W2263017585 hasConceptScore W2263017585C2779056158 @default.
- W2263017585 hasConceptScore W2263017585C2779978075 @default.
- W2263017585 hasConceptScore W2263017585C2780199535 @default.
- W2263017585 hasConceptScore W2263017585C2780306776 @default.
- W2263017585 hasConceptScore W2263017585C2780580376 @default.
- W2263017585 hasConceptScore W2263017585C2780852908 @default.
- W2263017585 hasConceptScore W2263017585C2909406889 @default.
- W2263017585 hasConceptScore W2263017585C71924100 @default.
- W2263017585 hasIssue "2" @default.
- W2263017585 hasLocation W22630175851 @default.
- W2263017585 hasOpenAccess W2263017585 @default.
- W2263017585 hasPrimaryLocation W22630175851 @default.
- W2263017585 hasVolume "6" @default.
- W2263017585 isParatext "false" @default.
- W2263017585 isRetracted "false" @default.
- W2263017585 magId "2263017585" @default.
- W2263017585 workType "article" @default.